In Depth 14 Apr 2023
mRNA vaccines: a promising future
In 1978, nearly two decades after the discovery of messenger RNA (mRNA), the concept of a vaccine made from mRNA was materialized. Like its name suggests, mRNAs are messengers that…
Cancer
- Latest Posts
Best in Biotech 15 Mar 2023
10 immunotherapy companies making waves in 2023
Immunotherapy has been widely studied in cancer treatment research, ever since William Coley, who is regarded as the father of immunotherapy, first attempted to leverage the immune system for oncological…
In Depth 13 Oct 2023
How close are we to a cure for metastatic breast cancer?
Currently considered an incurable disease, there is a lot of work being done around developing better treatment options for metastatic breast cancer, and, ultimately, a cure. Numerous promising candidates are…
Podcast 13 Oct 2023
Beyond Biotech podcast 67 – natural killer cells
This week, we speak to Artiva Biotherapeutics’ CEO, Fred Aslan, M.D. The company has demonstrated the potential for efficacy and safety with natural killer (NK) cells in two cancer clinical…
ADVERTISEMENT
In Depth 6 Oct 2023
Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?
It was predicted that more than 600,000 people would die from cancer last year in the U.S., according to the American Cancer Society. But what if those figures could be…
In Depth 4 Oct 2023
CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?
Riding on the success of CAR-T cell therapy, a breakthrough in the treatment of blood cancers, CAR-NK therapies are an emerging field in therapeutic research that aim to boost an…
News and Trends 10 Nov 2022
New radiopharmaceutical shrinks prostate cancer tumors
Researchers in Japan and Germany say a radiopharmaceutical treatment targeting a prostate-specific membrane antigen effectively shrinks prostate tumors in mice. The team reported the anti-cancer treatment zeroes in on tumor…
News and Trends 5 May 2023
Convergent Therapeutics to use $90M funding to treat cancer with radiopharmaceuticals
Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment of cancer, today announced the completion of a $90 million Series A financing.…
News and Trends 5 May 2023
Promising results from phase 3 prostate cancer study
Astellas Pharma Inc. and Pfizer Inc. have announced trial results from a phase 3 study on prostate cancer. The results showed XTANDI (enzalutamide) plus leuprolide significantly reduced the risk of…
In Depth 11 Oct 2022
The biggest private biotech investments in September 2022
The companies Acelyrin, InnovaFeed and Arsenal Biosciences bagged the biggest biotech investments in September 2022, with insect protein and cell therapies attracting big funding rounds. Autumn is in full swing…
Best in Biotech 30 Aug 2023
Five North Carolina biotech companies making their mark
North Carolina is home to Research Triangle Park, an R&D sanctuary situated between the cities of Raleigh and Durham, which just happens to be one of the biggest biotech hubs…
News and Trends 22 Sep 2022
New study shows how prostate cancer may start
Researchers at the University of East Anglia in the U.K. say they have made an important discovery about how prostate cancer may start to develop. A new study published in…
